Global GLP-1 Receptor Antagonist Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
GLP-1 receptor antagonists are a class of drugs used to treat metabolic diseases such as type 2 diabetes and obesity. They act on the GLP-1 receptor and inhibit the binding of GLP-1 to its receptor, thus blocking the biological effects of GLP-1. These drugs reduce insulin secretion by reducing the effects of GLP-1 and are often used to control blood sugar levels and weight. GLP-1 receptor antagonists are the opposite of GLP-1 receptor agonists, which are drugs that stimulate GLP-1 receptors and promote the biological effects of GLP-1.
The global GLP-1 Receptor Antagonist market size is projected to grow from US$ 3696 million in 2024 to US$ 5557 million in 2030; it is expected to grow at a CAGR of 7.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Receptor Antagonist Industry Forecast” looks at past sales and reviews total world GLP-1 Receptor Antagonist sales in 2023, providing a comprehensive analysis by region and market sector of projected GLP-1 Receptor Antagonist sales for 2024 through 2030. With GLP-1 Receptor Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Receptor Antagonist industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Receptor Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Receptor Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Receptor Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Receptor Antagonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Receptor Antagonist.
From the perspective of market size and growth trends, the GLP-1 drug market is growing rapidly. It has achieved great success in sales due to its excellent patient compliance. Take dulaglutide and semaglutide as examples. The global sales of these two drugs in 2022 will reach US$7.44 billion and US$9.342 billion respectively. In addition, the market value of two major pharmaceutical companies, Novo Nordisk and Eli Lilly, has soared due to the popularity of GLP-1 drugs. In the diabetes drug market, GLP-1 drugs have a market share of 39%, surpassing insulin to become the largest type of diabetes treatment drug in the world. In general, the market for GLP-1 receptor antagonists (or GLP-1 receptor agonists) is developing rapidly, and long-acting and oral administration are the main development trends in the future.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Receptor Antagonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global GLP-1 Receptor Antagonist market?
What factors are driving GLP-1 Receptor Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Receptor Antagonist market opportunities vary by end market size?
How does GLP-1 Receptor Antagonist break out by Type, by Application?
GLP-1 receptor antagonists are a class of drugs used to treat metabolic diseases such as type 2 diabetes and obesity. They act on the GLP-1 receptor and inhibit the binding of GLP-1 to its receptor, thus blocking the biological effects of GLP-1. These drugs reduce insulin secretion by reducing the effects of GLP-1 and are often used to control blood sugar levels and weight. GLP-1 receptor antagonists are the opposite of GLP-1 receptor agonists, which are drugs that stimulate GLP-1 receptors and promote the biological effects of GLP-1.
The global GLP-1 Receptor Antagonist market size is projected to grow from US$ 3696 million in 2024 to US$ 5557 million in 2030; it is expected to grow at a CAGR of 7.0% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “GLP-1 Receptor Antagonist Industry Forecast” looks at past sales and reviews total world GLP-1 Receptor Antagonist sales in 2023, providing a comprehensive analysis by region and market sector of projected GLP-1 Receptor Antagonist sales for 2024 through 2030. With GLP-1 Receptor Antagonist sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world GLP-1 Receptor Antagonist industry.
This Insight Report provides a comprehensive analysis of the global GLP-1 Receptor Antagonist landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on GLP-1 Receptor Antagonist portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global GLP-1 Receptor Antagonist market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for GLP-1 Receptor Antagonist and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global GLP-1 Receptor Antagonist.
From the perspective of market size and growth trends, the GLP-1 drug market is growing rapidly. It has achieved great success in sales due to its excellent patient compliance. Take dulaglutide and semaglutide as examples. The global sales of these two drugs in 2022 will reach US$7.44 billion and US$9.342 billion respectively. In addition, the market value of two major pharmaceutical companies, Novo Nordisk and Eli Lilly, has soared due to the popularity of GLP-1 drugs. In the diabetes drug market, GLP-1 drugs have a market share of 39%, surpassing insulin to become the largest type of diabetes treatment drug in the world. In general, the market for GLP-1 receptor antagonists (or GLP-1 receptor agonists) is developing rapidly, and long-acting and oral administration are the main development trends in the future.
This report presents a comprehensive overview, market shares, and growth opportunities of GLP-1 Receptor Antagonist market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Injection
- Oral Agent
- Diabetes Treatment
- Research
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Novo Nordisk
- AstraZeneca
- Sanofi
- Eli Lilly
- Bayer
- Merck
- Shionogi
- Pfizer
- Jiangsu Hengrui Pharmaceuticals
- Shanghai Fosun Pharmaceutical (Group)
- Shanghai Pharmaceutical Industry Research Institute
What is the 10-year outlook for the global GLP-1 Receptor Antagonist market?
What factors are driving GLP-1 Receptor Antagonist market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do GLP-1 Receptor Antagonist market opportunities vary by end market size?
How does GLP-1 Receptor Antagonist break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Receptor Antagonist Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for GLP-1 Receptor Antagonist by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for GLP-1 Receptor Antagonist by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Receptor Antagonist Segment by Type
2.2.1 Injection
2.2.2 Oral Agent
2.3 GLP-1 Receptor Antagonist Sales by Type
2.3.1 Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
2.3.2 Global GLP-1 Receptor Antagonist Revenue and Market Share by Type (2019-2024)
2.3.3 Global GLP-1 Receptor Antagonist Sale Price by Type (2019-2024)
2.4 GLP-1 Receptor Antagonist Segment by Application
2.4.1 Diabetes Treatment
2.4.2 Research
2.4.3 Other
2.5 GLP-1 Receptor Antagonist Sales by Application
2.5.1 Global GLP-1 Receptor Antagonist Sale Market Share by Application (2019-2024)
2.5.2 Global GLP-1 Receptor Antagonist Revenue and Market Share by Application (2019-2024)
2.5.3 Global GLP-1 Receptor Antagonist Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Receptor Antagonist Breakdown Data by Company
3.1.1 Global GLP-1 Receptor Antagonist Annual Sales by Company (2019-2024)
3.1.2 Global GLP-1 Receptor Antagonist Sales Market Share by Company (2019-2024)
3.2 Global GLP-1 Receptor Antagonist Annual Revenue by Company (2019-2024)
3.2.1 Global GLP-1 Receptor Antagonist Revenue by Company (2019-2024)
3.2.2 Global GLP-1 Receptor Antagonist Revenue Market Share by Company (2019-2024)
3.3 Global GLP-1 Receptor Antagonist Sale Price by Company
3.4 Key Manufacturers GLP-1 Receptor Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Receptor Antagonist Product Location Distribution
3.4.2 Players GLP-1 Receptor Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 RECEPTOR ANTAGONIST BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Receptor Antagonist Market Size by Geographic Region (2019-2024)
4.1.1 Global GLP-1 Receptor Antagonist Annual Sales by Geographic Region (2019-2024)
4.1.2 Global GLP-1 Receptor Antagonist Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic GLP-1 Receptor Antagonist Market Size by Country/Region (2019-2024)
4.2.1 Global GLP-1 Receptor Antagonist Annual Sales by Country/Region (2019-2024)
4.2.2 Global GLP-1 Receptor Antagonist Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Receptor Antagonist Sales Growth
4.4 APAC GLP-1 Receptor Antagonist Sales Growth
4.5 Europe GLP-1 Receptor Antagonist Sales Growth
4.6 Middle East & Africa GLP-1 Receptor Antagonist Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Receptor Antagonist Sales by Country
5.1.1 Americas GLP-1 Receptor Antagonist Sales by Country (2019-2024)
5.1.2 Americas GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
5.2 Americas GLP-1 Receptor Antagonist Sales by Type (2019-2024)
5.3 Americas GLP-1 Receptor Antagonist Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Receptor Antagonist Sales by Region
6.1.1 APAC GLP-1 Receptor Antagonist Sales by Region (2019-2024)
6.1.2 APAC GLP-1 Receptor Antagonist Revenue by Region (2019-2024)
6.2 APAC GLP-1 Receptor Antagonist Sales by Type (2019-2024)
6.3 APAC GLP-1 Receptor Antagonist Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Receptor Antagonist by Country
7.1.1 Europe GLP-1 Receptor Antagonist Sales by Country (2019-2024)
7.1.2 Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
7.2 Europe GLP-1 Receptor Antagonist Sales by Type (2019-2024)
7.3 Europe GLP-1 Receptor Antagonist Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Receptor Antagonist by Country
8.1.1 Middle East & Africa GLP-1 Receptor Antagonist Sales by Country (2019-2024)
8.1.2 Middle East & Africa GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
8.2 Middle East & Africa GLP-1 Receptor Antagonist Sales by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Receptor Antagonist Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Receptor Antagonist
10.3 Manufacturing Process Analysis of GLP-1 Receptor Antagonist
10.4 Industry Chain Structure of GLP-1 Receptor Antagonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Receptor Antagonist Distributors
11.3 GLP-1 Receptor Antagonist Customer
12 WORLD FORECAST REVIEW FOR GLP-1 RECEPTOR ANTAGONIST BY GEOGRAPHIC REGION
12.1 Global GLP-1 Receptor Antagonist Market Size Forecast by Region
12.1.1 Global GLP-1 Receptor Antagonist Forecast by Region (2025-2030)
12.1.2 Global GLP-1 Receptor Antagonist Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global GLP-1 Receptor Antagonist Forecast by Type (2025-2030)
12.7 Global GLP-1 Receptor Antagonist Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.4.3 Eli Lilly GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.5.3 Bayer GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.6.3 Merck GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Shionogi
13.7.1 Shionogi Company Information
13.7.2 Shionogi GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.7.3 Shionogi GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shionogi Main Business Overview
13.7.5 Shionogi Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.8.3 Pfizer GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Jiangsu Hengrui Pharmaceuticals
13.9.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.9.2 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.9.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.10 Shanghai Fosun Pharmaceutical (Group)
13.10.1 Shanghai Fosun Pharmaceutical (Group) Company Information
13.10.2 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.10.3 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Fosun Pharmaceutical (Group) Main Business Overview
13.10.5 Shanghai Fosun Pharmaceutical (Group) Latest Developments
13.11 Shanghai Pharmaceutical Industry Research Institute
13.11.1 Shanghai Pharmaceutical Industry Research Institute Company Information
13.11.2 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.11.3 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai Pharmaceutical Industry Research Institute Main Business Overview
13.11.5 Shanghai Pharmaceutical Industry Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global GLP-1 Receptor Antagonist Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for GLP-1 Receptor Antagonist by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for GLP-1 Receptor Antagonist by Country/Region, 2019, 2023 & 2030
2.2 GLP-1 Receptor Antagonist Segment by Type
2.2.1 Injection
2.2.2 Oral Agent
2.3 GLP-1 Receptor Antagonist Sales by Type
2.3.1 Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
2.3.2 Global GLP-1 Receptor Antagonist Revenue and Market Share by Type (2019-2024)
2.3.3 Global GLP-1 Receptor Antagonist Sale Price by Type (2019-2024)
2.4 GLP-1 Receptor Antagonist Segment by Application
2.4.1 Diabetes Treatment
2.4.2 Research
2.4.3 Other
2.5 GLP-1 Receptor Antagonist Sales by Application
2.5.1 Global GLP-1 Receptor Antagonist Sale Market Share by Application (2019-2024)
2.5.2 Global GLP-1 Receptor Antagonist Revenue and Market Share by Application (2019-2024)
2.5.3 Global GLP-1 Receptor Antagonist Sale Price by Application (2019-2024)
3 GLOBAL BY COMPANY
3.1 Global GLP-1 Receptor Antagonist Breakdown Data by Company
3.1.1 Global GLP-1 Receptor Antagonist Annual Sales by Company (2019-2024)
3.1.2 Global GLP-1 Receptor Antagonist Sales Market Share by Company (2019-2024)
3.2 Global GLP-1 Receptor Antagonist Annual Revenue by Company (2019-2024)
3.2.1 Global GLP-1 Receptor Antagonist Revenue by Company (2019-2024)
3.2.2 Global GLP-1 Receptor Antagonist Revenue Market Share by Company (2019-2024)
3.3 Global GLP-1 Receptor Antagonist Sale Price by Company
3.4 Key Manufacturers GLP-1 Receptor Antagonist Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GLP-1 Receptor Antagonist Product Location Distribution
3.4.2 Players GLP-1 Receptor Antagonist Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GLP-1 RECEPTOR ANTAGONIST BY GEOGRAPHIC REGION
4.1 World Historic GLP-1 Receptor Antagonist Market Size by Geographic Region (2019-2024)
4.1.1 Global GLP-1 Receptor Antagonist Annual Sales by Geographic Region (2019-2024)
4.1.2 Global GLP-1 Receptor Antagonist Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic GLP-1 Receptor Antagonist Market Size by Country/Region (2019-2024)
4.2.1 Global GLP-1 Receptor Antagonist Annual Sales by Country/Region (2019-2024)
4.2.2 Global GLP-1 Receptor Antagonist Annual Revenue by Country/Region (2019-2024)
4.3 Americas GLP-1 Receptor Antagonist Sales Growth
4.4 APAC GLP-1 Receptor Antagonist Sales Growth
4.5 Europe GLP-1 Receptor Antagonist Sales Growth
4.6 Middle East & Africa GLP-1 Receptor Antagonist Sales Growth
5 AMERICAS
5.1 Americas GLP-1 Receptor Antagonist Sales by Country
5.1.1 Americas GLP-1 Receptor Antagonist Sales by Country (2019-2024)
5.1.2 Americas GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
5.2 Americas GLP-1 Receptor Antagonist Sales by Type (2019-2024)
5.3 Americas GLP-1 Receptor Antagonist Sales by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GLP-1 Receptor Antagonist Sales by Region
6.1.1 APAC GLP-1 Receptor Antagonist Sales by Region (2019-2024)
6.1.2 APAC GLP-1 Receptor Antagonist Revenue by Region (2019-2024)
6.2 APAC GLP-1 Receptor Antagonist Sales by Type (2019-2024)
6.3 APAC GLP-1 Receptor Antagonist Sales by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe GLP-1 Receptor Antagonist by Country
7.1.1 Europe GLP-1 Receptor Antagonist Sales by Country (2019-2024)
7.1.2 Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
7.2 Europe GLP-1 Receptor Antagonist Sales by Type (2019-2024)
7.3 Europe GLP-1 Receptor Antagonist Sales by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa GLP-1 Receptor Antagonist by Country
8.1.1 Middle East & Africa GLP-1 Receptor Antagonist Sales by Country (2019-2024)
8.1.2 Middle East & Africa GLP-1 Receptor Antagonist Revenue by Country (2019-2024)
8.2 Middle East & Africa GLP-1 Receptor Antagonist Sales by Type (2019-2024)
8.3 Middle East & Africa GLP-1 Receptor Antagonist Sales by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GLP-1 Receptor Antagonist
10.3 Manufacturing Process Analysis of GLP-1 Receptor Antagonist
10.4 Industry Chain Structure of GLP-1 Receptor Antagonist
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GLP-1 Receptor Antagonist Distributors
11.3 GLP-1 Receptor Antagonist Customer
12 WORLD FORECAST REVIEW FOR GLP-1 RECEPTOR ANTAGONIST BY GEOGRAPHIC REGION
12.1 Global GLP-1 Receptor Antagonist Market Size Forecast by Region
12.1.1 Global GLP-1 Receptor Antagonist Forecast by Region (2025-2030)
12.1.2 Global GLP-1 Receptor Antagonist Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country (2025-2030)
12.3 APAC Forecast by Region (2025-2030)
12.4 Europe Forecast by Country (2025-2030)
12.5 Middle East & Africa Forecast by Country (2025-2030)
12.6 Global GLP-1 Receptor Antagonist Forecast by Type (2025-2030)
12.7 Global GLP-1 Receptor Antagonist Forecast by Application (2025-2030)
13 KEY PLAYERS ANALYSIS
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Information
13.1.2 Novo Nordisk GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.1.3 Novo Nordisk GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Novo Nordisk Main Business Overview
13.1.5 Novo Nordisk Latest Developments
13.2 AstraZeneca
13.2.1 AstraZeneca Company Information
13.2.2 AstraZeneca GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.2.3 AstraZeneca GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 AstraZeneca Main Business Overview
13.2.5 AstraZeneca Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.3.3 Sanofi GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 Eli Lilly
13.4.1 Eli Lilly Company Information
13.4.2 Eli Lilly GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.4.3 Eli Lilly GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Eli Lilly Main Business Overview
13.4.5 Eli Lilly Latest Developments
13.5 Bayer
13.5.1 Bayer Company Information
13.5.2 Bayer GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.5.3 Bayer GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Bayer Main Business Overview
13.5.5 Bayer Latest Developments
13.6 Merck
13.6.1 Merck Company Information
13.6.2 Merck GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.6.3 Merck GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Merck Main Business Overview
13.6.5 Merck Latest Developments
13.7 Shionogi
13.7.1 Shionogi Company Information
13.7.2 Shionogi GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.7.3 Shionogi GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Shionogi Main Business Overview
13.7.5 Shionogi Latest Developments
13.8 Pfizer
13.8.1 Pfizer Company Information
13.8.2 Pfizer GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.8.3 Pfizer GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Pfizer Main Business Overview
13.8.5 Pfizer Latest Developments
13.9 Jiangsu Hengrui Pharmaceuticals
13.9.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.9.2 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.9.3 Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.9.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.10 Shanghai Fosun Pharmaceutical (Group)
13.10.1 Shanghai Fosun Pharmaceutical (Group) Company Information
13.10.2 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.10.3 Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Shanghai Fosun Pharmaceutical (Group) Main Business Overview
13.10.5 Shanghai Fosun Pharmaceutical (Group) Latest Developments
13.11 Shanghai Pharmaceutical Industry Research Institute
13.11.1 Shanghai Pharmaceutical Industry Research Institute Company Information
13.11.2 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product Portfolios and Specifications
13.11.3 Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Shanghai Pharmaceutical Industry Research Institute Main Business Overview
13.11.5 Shanghai Pharmaceutical Industry Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. GLP-1 Receptor Antagonist Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. GLP-1 Receptor Antagonist Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral Agent
Table 5. Global GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 6. Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Table 7. Global GLP-1 Receptor Antagonist Revenue by Type (2019-2024) & ($ million)
Table 8. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2024)
Table 9. Global GLP-1 Receptor Antagonist Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global GLP-1 Receptor Antagonist Sale by Application (2019-2024) & (K Dose)
Table 11. Global GLP-1 Receptor Antagonist Sale Market Share by Application (2019-2024)
Table 12. Global GLP-1 Receptor Antagonist Revenue by Application (2019-2024) & ($ million)
Table 13. Global GLP-1 Receptor Antagonist Revenue Market Share by Application (2019-2024)
Table 14. Global GLP-1 Receptor Antagonist Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global GLP-1 Receptor Antagonist Sales by Company (2019-2024) & (K Dose)
Table 16. Global GLP-1 Receptor Antagonist Sales Market Share by Company (2019-2024)
Table 17. Global GLP-1 Receptor Antagonist Revenue by Company (2019-2024) & ($ millions)
Table 18. Global GLP-1 Receptor Antagonist Revenue Market Share by Company (2019-2024)
Table 19. Global GLP-1 Receptor Antagonist Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers GLP-1 Receptor Antagonist Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Receptor Antagonist Products Offered
Table 22. GLP-1 Receptor Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Receptor Antagonist Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global GLP-1 Receptor Antagonist Sales Market Share Geographic Region (2019-2024)
Table 27. Global GLP-1 Receptor Antagonist Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global GLP-1 Receptor Antagonist Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global GLP-1 Receptor Antagonist Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2019-2024)
Table 31. Global GLP-1 Receptor Antagonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global GLP-1 Receptor Antagonist Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 34. Americas GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2024)
Table 35. Americas GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 37. Americas GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 38. APAC GLP-1 Receptor Antagonist Sales by Region (2019-2024) & (K Dose)
Table 39. APAC GLP-1 Receptor Antagonist Sales Market Share by Region (2019-2024)
Table 40. APAC GLP-1 Receptor Antagonist Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 42. APAC GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 43. Europe GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 44. Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 46. Europe GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Receptor Antagonist
Table 52. Key Market Challenges & Risks of GLP-1 Receptor Antagonist
Table 53. Key Industry Trends of GLP-1 Receptor Antagonist
Table 54. GLP-1 Receptor Antagonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Receptor Antagonist Distributors List
Table 57. GLP-1 Receptor Antagonist Customer List
Table 58. Global GLP-1 Receptor Antagonist Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global GLP-1 Receptor Antagonist Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas GLP-1 Receptor Antagonist Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC GLP-1 Receptor Antagonist Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC GLP-1 Receptor Antagonist Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe GLP-1 Receptor Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa GLP-1 Receptor Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global GLP-1 Receptor Antagonist Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global GLP-1 Receptor Antagonist Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global GLP-1 Receptor Antagonist Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global GLP-1 Receptor Antagonist Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 84. Sanofi GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Eli Lilly Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 89. Eli Lilly GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Eli Lilly Main Business
Table 91. Eli Lilly Latest Developments
Table 92. Bayer Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 94. Bayer GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Merck Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 99. Merck GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Shionogi Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 103. Shionogi GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 104. Shionogi GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Shionogi Main Business
Table 106. Shionogi Latest Developments
Table 107. Pfizer Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 109. Pfizer GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Jiangsu Hengrui Pharmaceuticals Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 114. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Jiangsu Hengrui Pharmaceuticals Main Business
Table 116. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 117. Shanghai Fosun Pharmaceutical (Group) Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 119. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Shanghai Fosun Pharmaceutical (Group) Main Business
Table 121. Shanghai Fosun Pharmaceutical (Group) Latest Developments
Table 122. Shanghai Pharmaceutical Industry Research Institute Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 124. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Shanghai Pharmaceutical Industry Research Institute Main Business
Table 126. Shanghai Pharmaceutical Industry Research Institute Latest Developments
Table 1. GLP-1 Receptor Antagonist Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. GLP-1 Receptor Antagonist Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Injection
Table 4. Major Players of Oral Agent
Table 5. Global GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 6. Global GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Table 7. Global GLP-1 Receptor Antagonist Revenue by Type (2019-2024) & ($ million)
Table 8. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2024)
Table 9. Global GLP-1 Receptor Antagonist Sale Price by Type (2019-2024) & (US$/Dose)
Table 10. Global GLP-1 Receptor Antagonist Sale by Application (2019-2024) & (K Dose)
Table 11. Global GLP-1 Receptor Antagonist Sale Market Share by Application (2019-2024)
Table 12. Global GLP-1 Receptor Antagonist Revenue by Application (2019-2024) & ($ million)
Table 13. Global GLP-1 Receptor Antagonist Revenue Market Share by Application (2019-2024)
Table 14. Global GLP-1 Receptor Antagonist Sale Price by Application (2019-2024) & (US$/Dose)
Table 15. Global GLP-1 Receptor Antagonist Sales by Company (2019-2024) & (K Dose)
Table 16. Global GLP-1 Receptor Antagonist Sales Market Share by Company (2019-2024)
Table 17. Global GLP-1 Receptor Antagonist Revenue by Company (2019-2024) & ($ millions)
Table 18. Global GLP-1 Receptor Antagonist Revenue Market Share by Company (2019-2024)
Table 19. Global GLP-1 Receptor Antagonist Sale Price by Company (2019-2024) & (US$/Dose)
Table 20. Key Manufacturers GLP-1 Receptor Antagonist Producing Area Distribution and Sales Area
Table 21. Players GLP-1 Receptor Antagonist Products Offered
Table 22. GLP-1 Receptor Antagonist Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global GLP-1 Receptor Antagonist Sales by Geographic Region (2019-2024) & (K Dose)
Table 26. Global GLP-1 Receptor Antagonist Sales Market Share Geographic Region (2019-2024)
Table 27. Global GLP-1 Receptor Antagonist Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global GLP-1 Receptor Antagonist Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global GLP-1 Receptor Antagonist Sales by Country/Region (2019-2024) & (K Dose)
Table 30. Global GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2019-2024)
Table 31. Global GLP-1 Receptor Antagonist Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global GLP-1 Receptor Antagonist Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 34. Americas GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2024)
Table 35. Americas GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 36. Americas GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 37. Americas GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 38. APAC GLP-1 Receptor Antagonist Sales by Region (2019-2024) & (K Dose)
Table 39. APAC GLP-1 Receptor Antagonist Sales Market Share by Region (2019-2024)
Table 40. APAC GLP-1 Receptor Antagonist Revenue by Region (2019-2024) & ($ millions)
Table 41. APAC GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 42. APAC GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 43. Europe GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 44. Europe GLP-1 Receptor Antagonist Revenue by Country (2019-2024) & ($ millions)
Table 45. Europe GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 46. Europe GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 47. Middle East & Africa GLP-1 Receptor Antagonist Sales by Country (2019-2024) & (K Dose)
Table 48. Middle East & Africa GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Table 49. Middle East & Africa GLP-1 Receptor Antagonist Sales by Type (2019-2024) & (K Dose)
Table 50. Middle East & Africa GLP-1 Receptor Antagonist Sales by Application (2019-2024) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of GLP-1 Receptor Antagonist
Table 52. Key Market Challenges & Risks of GLP-1 Receptor Antagonist
Table 53. Key Industry Trends of GLP-1 Receptor Antagonist
Table 54. GLP-1 Receptor Antagonist Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. GLP-1 Receptor Antagonist Distributors List
Table 57. GLP-1 Receptor Antagonist Customer List
Table 58. Global GLP-1 Receptor Antagonist Sales Forecast by Region (2025-2030) & (K Dose)
Table 59. Global GLP-1 Receptor Antagonist Revenue Forecast by Region (2025-2030) & ($ millions)
Table 60. Americas GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 61. Americas GLP-1 Receptor Antagonist Annual Revenue Forecast by Country (2025-2030) & ($ millions)
Table 62. APAC GLP-1 Receptor Antagonist Sales Forecast by Region (2025-2030) & (K Dose)
Table 63. APAC GLP-1 Receptor Antagonist Annual Revenue Forecast by Region (2025-2030) & ($ millions)
Table 64. Europe GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 65. Europe GLP-1 Receptor Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 66. Middle East & Africa GLP-1 Receptor Antagonist Sales Forecast by Country (2025-2030) & (K Dose)
Table 67. Middle East & Africa GLP-1 Receptor Antagonist Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. Global GLP-1 Receptor Antagonist Sales Forecast by Type (2025-2030) & (K Dose)
Table 69. Global GLP-1 Receptor Antagonist Revenue Forecast by Type (2025-2030) & ($ millions)
Table 70. Global GLP-1 Receptor Antagonist Sales Forecast by Application (2025-2030) & (K Dose)
Table 71. Global GLP-1 Receptor Antagonist Revenue Forecast by Application (2025-2030) & ($ millions)
Table 72. Novo Nordisk Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 73. Novo Nordisk GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 74. Novo Nordisk GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 75. Novo Nordisk Main Business
Table 76. Novo Nordisk Latest Developments
Table 77. AstraZeneca Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 78. AstraZeneca GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 79. AstraZeneca GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 80. AstraZeneca Main Business
Table 81. AstraZeneca Latest Developments
Table 82. Sanofi Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 83. Sanofi GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 84. Sanofi GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 85. Sanofi Main Business
Table 86. Sanofi Latest Developments
Table 87. Eli Lilly Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 88. Eli Lilly GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 89. Eli Lilly GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 90. Eli Lilly Main Business
Table 91. Eli Lilly Latest Developments
Table 92. Bayer Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 93. Bayer GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 94. Bayer GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 95. Bayer Main Business
Table 96. Bayer Latest Developments
Table 97. Merck Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 98. Merck GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 99. Merck GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 100. Merck Main Business
Table 101. Merck Latest Developments
Table 102. Shionogi Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 103. Shionogi GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 104. Shionogi GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 105. Shionogi Main Business
Table 106. Shionogi Latest Developments
Table 107. Pfizer Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 108. Pfizer GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 109. Pfizer GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 110. Pfizer Main Business
Table 111. Pfizer Latest Developments
Table 112. Jiangsu Hengrui Pharmaceuticals Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 113. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 114. Jiangsu Hengrui Pharmaceuticals GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 115. Jiangsu Hengrui Pharmaceuticals Main Business
Table 116. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 117. Shanghai Fosun Pharmaceutical (Group) Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 118. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 119. Shanghai Fosun Pharmaceutical (Group) GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 120. Shanghai Fosun Pharmaceutical (Group) Main Business
Table 121. Shanghai Fosun Pharmaceutical (Group) Latest Developments
Table 122. Shanghai Pharmaceutical Industry Research Institute Basic Information, GLP-1 Receptor Antagonist Manufacturing Base, Sales Area and Its Competitors
Table 123. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Product Portfolios and Specifications
Table 124. Shanghai Pharmaceutical Industry Research Institute GLP-1 Receptor Antagonist Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 125. Shanghai Pharmaceutical Industry Research Institute Main Business
Table 126. Shanghai Pharmaceutical Industry Research Institute Latest Developments
LIST OF FIGURES
Figure 1. Picture of GLP-1 Receptor Antagonist
Figure 2. GLP-1 Receptor Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Receptor Antagonist Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global GLP-1 Receptor Antagonist Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. GLP-1 Receptor Antagonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2023)
Figure 10. GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral Agent
Figure 13. Global GLP-1 Receptor Antagonist Sales Market Share by Type in 2023
Figure 14. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2024)
Figure 15. GLP-1 Receptor Antagonist Consumed in Diabetes Treatment
Figure 16. Global GLP-1 Receptor Antagonist Market: Diabetes Treatment (2019-2024) & (K Dose)
Figure 17. GLP-1 Receptor Antagonist Consumed in Research
Figure 18. Global GLP-1 Receptor Antagonist Market: Research (2019-2024) & (K Dose)
Figure 19. GLP-1 Receptor Antagonist Consumed in Other
Figure 20. Global GLP-1 Receptor Antagonist Market: Other (2019-2024) & (K Dose)
Figure 21. Global GLP-1 Receptor Antagonist Sale Market Share by Application (2023)
Figure 22. Global GLP-1 Receptor Antagonist Revenue Market Share by Application in 2023
Figure 23. GLP-1 Receptor Antagonist Sales by Company in 2023 (K Dose)
Figure 24. Global GLP-1 Receptor Antagonist Sales Market Share by Company in 2023
Figure 25. GLP-1 Receptor Antagonist Revenue by Company in 2023 ($ millions)
Figure 26. Global GLP-1 Receptor Antagonist Revenue Market Share by Company in 2023
Figure 27. Global GLP-1 Receptor Antagonist Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global GLP-1 Receptor Antagonist Revenue Market Share by Geographic Region in 2023
Figure 29. Americas GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 30. Americas GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 31. APAC GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 32. APAC GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 33. Europe GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 34. Europe GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 36. Middle East & Africa GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 37. Americas GLP-1 Receptor Antagonist Sales Market Share by Country in 2023
Figure 38. Americas GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Figure 39. Americas GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 40. Americas GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 41. United States GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC GLP-1 Receptor Antagonist Sales Market Share by Region in 2023
Figure 46. APAC GLP-1 Receptor Antagonist Revenue Market Share by Region (2019-2024)
Figure 47. APAC GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 48. APAC GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 49. China GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 53. India GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe GLP-1 Receptor Antagonist Sales Market Share by Country in 2023
Figure 57. Europe GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Figure 58. Europe GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 59. Europe GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 60. Germany GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 61. France GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 62. UK GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 68. Egypt GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of GLP-1 Receptor Antagonist in 2023
Figure 74. Manufacturing Process Analysis of GLP-1 Receptor Antagonist
Figure 75. Industry Chain Structure of GLP-1 Receptor Antagonist
Figure 76. Channels of Distribution
Figure 77. Global GLP-1 Receptor Antagonist Sales Market Forecast by Region (2025-2030)
Figure 78. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global GLP-1 Receptor Antagonist Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global GLP-1 Receptor Antagonist Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of GLP-1 Receptor Antagonist
Figure 2. GLP-1 Receptor Antagonist Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GLP-1 Receptor Antagonist Sales Growth Rate 2019-2030 (K Dose)
Figure 7. Global GLP-1 Receptor Antagonist Revenue Growth Rate 2019-2030 ($ millions)
Figure 8. GLP-1 Receptor Antagonist Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 9. GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2023)
Figure 10. GLP-1 Receptor Antagonist Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 11. Product Picture of Injection
Figure 12. Product Picture of Oral Agent
Figure 13. Global GLP-1 Receptor Antagonist Sales Market Share by Type in 2023
Figure 14. Global GLP-1 Receptor Antagonist Revenue Market Share by Type (2019-2024)
Figure 15. GLP-1 Receptor Antagonist Consumed in Diabetes Treatment
Figure 16. Global GLP-1 Receptor Antagonist Market: Diabetes Treatment (2019-2024) & (K Dose)
Figure 17. GLP-1 Receptor Antagonist Consumed in Research
Figure 18. Global GLP-1 Receptor Antagonist Market: Research (2019-2024) & (K Dose)
Figure 19. GLP-1 Receptor Antagonist Consumed in Other
Figure 20. Global GLP-1 Receptor Antagonist Market: Other (2019-2024) & (K Dose)
Figure 21. Global GLP-1 Receptor Antagonist Sale Market Share by Application (2023)
Figure 22. Global GLP-1 Receptor Antagonist Revenue Market Share by Application in 2023
Figure 23. GLP-1 Receptor Antagonist Sales by Company in 2023 (K Dose)
Figure 24. Global GLP-1 Receptor Antagonist Sales Market Share by Company in 2023
Figure 25. GLP-1 Receptor Antagonist Revenue by Company in 2023 ($ millions)
Figure 26. Global GLP-1 Receptor Antagonist Revenue Market Share by Company in 2023
Figure 27. Global GLP-1 Receptor Antagonist Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global GLP-1 Receptor Antagonist Revenue Market Share by Geographic Region in 2023
Figure 29. Americas GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 30. Americas GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 31. APAC GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 32. APAC GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 33. Europe GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 34. Europe GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 35. Middle East & Africa GLP-1 Receptor Antagonist Sales 2019-2024 (K Dose)
Figure 36. Middle East & Africa GLP-1 Receptor Antagonist Revenue 2019-2024 ($ millions)
Figure 37. Americas GLP-1 Receptor Antagonist Sales Market Share by Country in 2023
Figure 38. Americas GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Figure 39. Americas GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 40. Americas GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 41. United States GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 42. Canada GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 43. Mexico GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 44. Brazil GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 45. APAC GLP-1 Receptor Antagonist Sales Market Share by Region in 2023
Figure 46. APAC GLP-1 Receptor Antagonist Revenue Market Share by Region (2019-2024)
Figure 47. APAC GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 48. APAC GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 49. China GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 50. Japan GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 51. South Korea GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 52. Southeast Asia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 53. India GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 54. Australia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 55. China Taiwan GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 56. Europe GLP-1 Receptor Antagonist Sales Market Share by Country in 2023
Figure 57. Europe GLP-1 Receptor Antagonist Revenue Market Share by Country (2019-2024)
Figure 58. Europe GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 59. Europe GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 60. Germany GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 61. France GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 62. UK GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 63. Italy GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 64. Russia GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 65. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Country (2019-2024)
Figure 66. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Type (2019-2024)
Figure 67. Middle East & Africa GLP-1 Receptor Antagonist Sales Market Share by Application (2019-2024)
Figure 68. Egypt GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 69. South Africa GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 70. Israel GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 71. Turkey GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 72. GCC Countries GLP-1 Receptor Antagonist Revenue Growth 2019-2024 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of GLP-1 Receptor Antagonist in 2023
Figure 74. Manufacturing Process Analysis of GLP-1 Receptor Antagonist
Figure 75. Industry Chain Structure of GLP-1 Receptor Antagonist
Figure 76. Channels of Distribution
Figure 77. Global GLP-1 Receptor Antagonist Sales Market Forecast by Region (2025-2030)
Figure 78. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Region (2025-2030)
Figure 79. Global GLP-1 Receptor Antagonist Sales Market Share Forecast by Type (2025-2030)
Figure 80. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Type (2025-2030)
Figure 81. Global GLP-1 Receptor Antagonist Sales Market Share Forecast by Application (2025-2030)
Figure 82. Global GLP-1 Receptor Antagonist Revenue Market Share Forecast by Application (2025-2030)
